Is Mounjaro FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Mounjaro is FDA approved and how it is commonly categorized.
Overview
Mounjaro is a prescription medication containing tirzepatide, a dual GIP and GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes.
FDA Status Details
Mounjaro is classified as FDA Approved as a branded prescription medication. Approval applies specifically to its labeled indications, dosage forms, and manufacturer.
Brand Names & Variants
Mounjaro contains tirzepatide, which is also marketed under the brand name Zepbound for chronic weight management under separate FDA approval.
Compounded & Private Label Considerations
Compounded tirzepatide products are not FDA approved. Products marketed outside regulated pharmacy channels may not meet FDA standards for safety, quality, or consistency.
Search Another Drug or Compound
Use DrugStatusIndex to review regulatory status information.